patient dose
screening dose
patient survival
clinical benefits of spectral CT
lung nodule detection
lower dose limit
Fewer false positives
Excellent lung cancer imaging
low-dose CT screening of high-risk individuals
patient distress
particular future lung cancer patients
potential of spectral CT
lower clinical costs
expected clinical gain
high rate of false positives
generation computed tomography Lung cancer
spectral silicon detector
higher resolution
exceptional clinical expertise
management of patient studies
cases of induced cancer
training
early detection
high-impact research
image analysis
world-class research
host group
reduced artefacts
fewer follow-ups
characterisation steps
cutting-edge detector technology
researcherâ€™s strong background
strong international collaborations
higher contrast sensitivity
novel image reconstruction techniques
tumour identification
commercial partners
highest incidence
characterisations
close ties
medical physics
workload
increased radiation exposure
society
networking opportunities
public awareness
mortality rates
cancers
outreach activities
career prospects
current state
partner organisation
photon
method
concerns
major health organisations
reduction
hypothesis
fellowship